Showing results (21-30 of 3,343) with videos related to
Sort By:
Pageof 335
Expert Opinion on Investigational Drugs|March 1, 2021
Investigational neuroprotective compounds in clinical trials for retinal diseaseDaniel Hill, Chiara Compagnoni, M Francesca CordeiroCurrent Eye Research|October 27, 2007
Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopesAnnelie Maass, Peter Lundh von Leithner, Vy Luong, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 6, 2020
Detecting Apoptosis as a Clinical Endpoint for Proof of a Clinical PrinciplePiero Zollet, Timothy E Yap, M Francesca CordeiroJournal of the American Dental Association (1939)|June 22, 2005
A review of the management of endodontically treated teeth. Post, core and the final restorationWilliam CheungSeizure|August 3, 2025
Retinal thinning in epilepsy: A meta-analysisThomas Chontos, Richard Nicholas, M Francesca Cordeiro, et al.Cell and Tissue Research|February 2, 2013
The potential of annexin-labelling for the diagnosis and follow-up of glaucomaEduardo M Normando, Lisa A Turner, M Francesca CordeiroScientific Reports|February 27, 2020
Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degenerationLi Guo, Benjamin M Davis, Nivedita Ravindran, et al.BMC Bioinformatics|June 7, 2014
A semi-automated technique for labeling and counting of apoptosing retinal cellsMukhtar Bizrah, Steve C Dakin, Li Guo, et al.Scientific Reports|December 11, 2020
Dynamic changes in cell size and corresponding cell fate after optic nerve injuryBenjamin M Davis, Li Guo, Nivedita Ravindran, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 5, 2015
Current perspective of neuroprotection and glaucomaKailin Tian, Shannon Shibata-Germanos, Milena Pahlitzsch, et al.Pageof 335